Vaxcyte Stock

Vaxcyte P/B

The P/B (Price-to-Book Ratio) of Vaxcyte (PCVX) as of Aug 21, 2026 is 2.89. In the previous year, P/B (Price-to-Book Ratio) was 2.35 — a change of 23.10% (higher).

P/B

2.89

YoY

23.10%

Last updated:

P/B (Price-to-Book Ratio) of Vaxcyte is 2026 2.89 . P/B (Price-to-Book Ratio) of Vaxcyte was 2025 2.35 . It decreases by 23.10% higher compared to the previous year.
Access this data via the Eulerpool API

Vaxcyte Stock analysis

What does Vaxcyte do? Vaxcyte Inc is a global biopharmaceutical company focused on the discovery, development, and commercialization of vaccines for various diseases. The company was founded in 2018 and is headquartered in Foster City, California. Vaxcyte is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vaxcyte stock

P/B (Price-to-Book Ratio) of Vaxcyte is 2.89 in 2026.

P/B (Price-to-Book Ratio) of Vaxcyte changed from 2.35 to 2.89, representing a 23.10% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Vaxcyte since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Vaxcyte with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Vaxcyte

All Key Metrics — Vaxcyte